newsfilter
← Latest News
GlobeNewswire·

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

• Shareholders overwhelmingly vote in favour of Cybin's acquisition of Small Pharma, supporting the combined company's vision to build an international clinical-stage leader in psychedelic-based therapeutics LONDON,